Amrinone‐Mediated Thrombocytopenia

Evlin L. Kinney; James O. Ballard; Brian Carlin; Robert Zelis

doi:10.1111/j.1600-0609.1983.tb00665.x

Amrinone‐Mediated Thrombocytopenia

Evlin L. Kinney
, James O. Ballard
, Brian Carlin
, Robert Zelis

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Abstract

Amrinone, a new cardioactive drug, was administered for, on average, 27.9 d to 12 patients in severe congestive heart failure. Thrombocytopenia occurred in 4 patients, while a progressive decline in platelet numbers developed in 3 additional patients. The mechanism for these adverse effects of amrinone is unclear, but merits further study because of its frequency.

Original language	English (US)
Pages (from-to)	376-380
Number of pages	5
Journal	Scandinavian Journal of Haematology
Volume	31
Issue number	4
DOIs	https://doi.org/10.1111/j.1600-0609.1983.tb00665.x
State	Published - Oct 1983

All Science Journal Classification (ASJC) codes

Hematology

Access to Document

10.1111/j.1600-0609.1983.tb00665.x

Cite this

@article{7c76401b031f433182ed8319614ebc63,

title = "Amrinone‐Mediated Thrombocytopenia",

abstract = "Amrinone, a new cardioactive drug, was administered for, on average, 27.9 d to 12 patients in severe congestive heart failure. Thrombocytopenia occurred in 4 patients, while a progressive decline in platelet numbers developed in 3 additional patients. The mechanism for these adverse effects of amrinone is unclear, but merits further study because of its frequency.",

author = "Kinney, \{Evlin L.\} and Ballard, \{James O.\} and Brian Carlin and Robert Zelis",

year = "1983",

month = oct,

doi = "10.1111/j.1600-0609.1983.tb00665.x",

language = "English (US)",

volume = "31",

pages = "376--380",

journal = "Scandinavian Journal of Haematology",

issn = "0036-553X",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - Amrinone‐Mediated Thrombocytopenia

AU - Kinney, Evlin L.

AU - Ballard, James O.

AU - Carlin, Brian

AU - Zelis, Robert

PY - 1983/10

Y1 - 1983/10

N2 - Amrinone, a new cardioactive drug, was administered for, on average, 27.9 d to 12 patients in severe congestive heart failure. Thrombocytopenia occurred in 4 patients, while a progressive decline in platelet numbers developed in 3 additional patients. The mechanism for these adverse effects of amrinone is unclear, but merits further study because of its frequency.

AB - Amrinone, a new cardioactive drug, was administered for, on average, 27.9 d to 12 patients in severe congestive heart failure. Thrombocytopenia occurred in 4 patients, while a progressive decline in platelet numbers developed in 3 additional patients. The mechanism for these adverse effects of amrinone is unclear, but merits further study because of its frequency.

UR - https://www.scopus.com/pages/publications/0020619456

UR - https://www.scopus.com/pages/publications/0020619456#tab=citedBy

U2 - 10.1111/j.1600-0609.1983.tb00665.x

DO - 10.1111/j.1600-0609.1983.tb00665.x

M3 - Article

C2 - 6622977

AN - SCOPUS:0020619456

SN - 0036-553X

VL - 31

SP - 376

EP - 380

JO - Scandinavian Journal of Haematology

JF - Scandinavian Journal of Haematology

IS - 4

ER -

Amrinone‐Mediated Thrombocytopenia

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this